Russia to start COVID-19 vaccine phase 3 trials in Aug - Breaking The News

Russia to start COVID-19 vaccine phase 3 trials in Aug

13 July

1 min read

EPA-EFE/DAVID MARIUZ AUSTRALIA AND NEW ZEALAND OUT

Scientists from Russian Gamaleya Institute are set to start the final third phase trials for its coronavirus vaccine in mid-August, the institute's head Alexander Ginsburg said on Monday.

"Around 14-15 August, I hope, the small amount of vaccine that we should be able to produce will enter public circulation," Ginsburg told RIA Novosti.

Previously, RIA reported that the first small-scale human trial of the vaccine developed by the Gamaleya Institute showed the vaccine is safe for human use.

coronavirus vaccine

Moderna gets greenlight for updated COVID jab

3 September

Moderna Inc. shared on Tuesday that it has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for its updated coronavirus vaccine, which targets the JN.1 variant of SARS-CoV-2."COVID-19 continues to present a serious health risk. Updated vaccines targeting circulating strains play a vital role in helping to protect those most at risk from severe illness and hospitalization, alleviating strain on the NHS," Britain's...

FDA greenlights updated Novavax COVID vaccine

30 August

The United States Food and Drug Administration (FDA) approved on Friday the emergency use of the Novavax COVID-19 vaccine for "individuals 12 years of age and older." The approval allows those previously vaccinated to receive one dose, while those who haven't been vaccinated will need two. Similar to the Moderna and Pfizer vaccines, this updated version specifically targets the omicron variant JN.1 of the virus while providing increased protection against...

FDA okays Moderna, Pfizer updated vaccines

22 August

The United States Food and Drug Administration approved on Thursday the emergency use of ModernaTX Inc. and Pfizer Inc.'s mRNA COVID-19 vaccines with updated formulations. The jabs target a strain called KP.2, a descendant of the highly contagious SARS-CoV-2 omicron subvariant JN.1, offering enhanced protection against severe outcomes such as hospitalization and death. The shots should be available in pharmacies "within days." "The updated...

EU Court: EC denied sufficient access to COVID jabs contracts

17 July

Court of Justice of the European Union (CJEU) ruled on Wednesday that the European Commission did not give the public "sufficiently wide access to COVID-19 vaccine contracts.""The Commission did not provide sufficient explanations as to how access to the definitions of 'wilful misconduct' or 'best reasonable efforts', in some of the agreements, and as to how access to the agreements' provisions on donations and resales of the vaccines, could...

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.